The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. LifeMD Inc shares valued at $249,690 were sold by Schreiber Justin on Jul 01 ’25. At $9.99 per share, Schreiber Justin sold 25,000 shares. The insider’s holdings dropped to 2,475,721 shares worth approximately $16.36 million following the completion of this transaction.
Also, Justin Schreiber purchased 175,000 shares, netting a total of over 1,821,750 in proceeds.
Before that, Schreiber Justin had sold 25,000 shares from its account. In a trade valued at $334,458, the Chairman and CEO traded LifeMD Inc shares for $13.38 each. Upon closing the transaction, the insider’s holdings decreased to 25,000 shares, worth approximately $16.53 million.
As published in a research note from BTIG Research on June 18, 2025, LifeMD Inc [LFMD] has been retained to a Buy and the price target has been revised to $18. Analysts at Lake Street started covering the stock with ‘”a Buy”‘ outlook in a report released in early December. As of December 04, 2024, Mizuho has initiated its “Neutral” rating for LFMD.
Analyzing LFMD Stock Performance
On last trading session, LifeMD Inc [NASDAQ: LFMD] rose 1.23% to $6.61. The stock’s lowest price that day was $6.4712, but it reached a high of $6.96 in the same session. During the last five days, there has been a drop of approximately -36.50%. Over the course of the year, LifeMD Inc shares have jumped approximately 10.54%.
Is LifeMD Inc subject to short interest?
Stocks of LifeMD Inc saw a sharp rise in short interest on 2025-07-15 jumping by 0.76 million shares to 4.34 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 3.58 million shares. A jump of 17.49% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.37 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.37.
Which companies own the most shares of LifeMD Inc (LFMD)?
In terms of LifeMD Inc share price expectations, FactSet research, analysts set an average price target of 16 in the next 12 months, up nearly 145.02% from the previous closing price of $6.53. Analysts anticipate LifeMD Inc stock to reach 18 by 2025, with the lowest price target being 14. In spite of this, 4 analysts ranked LifeMD Inc stock as Buy at the end of 2025. On June 05, 2024, KeyBanc Capital Markets assigned a price target of “an Overweight” to the stock and initiated coverage with a $12.
